Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mirm · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Buy
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$185
Consensus
$144
+55.2% upside
Low
$118
Median: $140 · Last Close: $92.66
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$143.80
55.2% upside
High Target
$185
99.7%
Low Target
$118
27.3%
Current Price
$92.66
as of today
Based on analyst price targets, the MIRM stock price prediction for the next 12 months ranges from $118 to $185. The consensus MIRM price forecast of $143.80 implies 55.2% upside from the current price of $92.66.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $88.50 | ↓ 4.49% |
1-day model range: $87.91–$89.08. Peak: $89.08 (-4.49%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $164 | +77.2% |
| 2028 | $240 | +159.3% |
| 2029 | $307 | +231.4% |
| 2030 | $358 | +286.7% |
| 2031 | — | +325.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MIRM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Baird | Maintains | Outperform→Outperform |
| 2026-05-07 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-07 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-05 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-29 | Stifel | Maintains | Buy→Buy |
| 2026-04-28 | Baird | Maintains | Outperform→Outperform |
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-21 | Citizens | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on Mirum Pharmaceuticals, Inc. (MIRM) stock. Of the recent 119 rating actions, 1 were upgrades and 0 were downgrades. 18 analysts currently cover MIRM.
Analyst Recommendation Trends
MIRM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 6 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$674M
↓ 36.3% YoY
Revenue Next Year
$811M
↑ 20.2% YoY
EPS This Year
$-15.65
EPS Next Year
$-0.68
↓ 95.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast MIRM EPS of $-15.65 for the current fiscal year, based on estimates from 7 analysts. The MIRM revenue forecast is $674M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MIRM stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MIRM price target is $143.80 (+55.2% upside), with an analyst consensus of Buy.
The MIRM short-term stock prediction for tomorrow is $88.50 (-4.49%). The MIRM stock price prediction for 2027 estimates an average of $164. The MIRM stock prediction for 2030 projects a range of $332–$384.
Mirum Pharmaceuticals, Inc. trades on NASDAQ under the ticker MIRM. The MIRM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
MIRM forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month MIRM price target is $143.80, with a high forecast of $185.00 and a low of $118.00. The median price target is shown in the chart above when available. This implies +55.2% potential upside from the current price of $92.66.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.